ClinicalTrials.govpublic full text
Assessment of Safety, Tolerability, Immunogenicity, and Pharmacokinetics of AZD3427
heart failure, heart failure with reduced ejection fraction, heart failure with ejection fraction of ≥ 41%, azd3427, first-time-in-human, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 826130
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.